Regional Kidney Paired Donor Exchange in Sensitized Patients

August 31, 2016 updated by: BiologicTx, LLC

Prospective, Multicenter, Observational Registry Study to Determine if Enrollment in a Regional Kidney Paired Donor Exchange Program Improves the Overall Rate of Kidney Transplantation in Sensitized Patients, and Sensitized Patients Undergoing Desensitization Treatments.

This is a prospective, multi-center, observational study to determine if a combination of desensitization and enrollment in a regional kidney paired donor (KPD) exchange program improves the overall rate of kidney transplantation in sensitized patients.

Study Overview

Study Type

Observational

Enrollment (Anticipated)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Washington
      • Seattle, Washington, United States, 98101
        • Recruiting
        • Virginia Mason Medical Center
        • Contact:
        • Principal Investigator:
          • Andrew Weiss, MD
      • Seattle, Washington, United States, 98104
        • Recruiting
        • Swedish Medical Center
        • Contact:
        • Principal Investigator:
          • Lisa Florence, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Approximately 250 renal transplant candidates at 6 transplantation centers in the United States (northwest) will participate.

Description

Inclusion Criteria:

  • A. Potential Recipients must meet the following inclusion criteria:

    1. Willing and able to sign an informed consent form
    2. Must be at least 18 years old
    3. Meet all recipient selection criteria of the transplant center
    4. Listed on the deceased donor kidney waiting list for renal transplant at a participating center
    5. Potential recipients must:

Group 1: have one or more medically suitable donors who are ABO incompatible or HLA incompatible (defined as positive serologic cross-match); or

Group 2: have a medically suitable donor that is otherwise deemed incompatible due to age, size, or other mismatch by their respective transplant center; or

Group 3: be listed on the deceased donor waiting list for ≥ one year without an identifiable living donor and have a PRA% ≥ 60%

B. Potential Living Donors must meet the following inclusion criteria:

  1. Must provide informed consent in accordance with the process outlined in the Informed Consent Requirements Section of the KPD Program Manual of Operations
  2. Must be at least 18 years old
  3. Meet all living donor selection criteria of the transplant center
  4. Meet the evaluation requirements set forth in the Living Donor Evaluation Section of the KPD Program Operational Guidelines

Exclusion Criteria:

  • C. Recipients

    1. Do not meet selection criteria of the transplant center
    2. Eligible compatible donor at the time of enrollment
    3. Inactive (not eligible to receive a kidney) on the deceased donor waitlist
    4. Pregnant or breast feeding

D. Donors

  1. Unwilling or unable to provide informed consent
  2. Have identified barriers to donation as set forth in the Living Donor Evaluation Section of the KPD Program Manual of Operations (Appendix A)
  3. Must not be currently listed as a potential living donor for any other recipient registered in the KPD system
  4. Pregnant or breast feeding

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The rate of kidney transplant in sensitized patients following desensitization and enrollment in a regional kidney paired donor exchange program
Time Frame: 24 months
The rate of kidney transplant in sensitized patients following desensitization and enrollment in a regional kidney paired donor exchange program will be summarized.
24 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Overall number of kidney transplants per center/region
Time Frame: 24 months
To determine the overall number of kidney transplants per center/region.
24 months

Other Outcome Measures

Outcome Measure
Time Frame
The overall number of KPD matches in the region
Time Frame: 24 months
24 months
Donor types (direct, paired exchange, altruistic)
Time Frame: 24 months
24 months
The overall number of KPD exchange recipients transplanted in the region
Time Frame: 24 months
24 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Lisa Florence, MD, Swedish Medical Center
  • Principal Investigator: Andrew Weiss, MD, Virginia Mason Medical Center
  • Principal Investigator: Douglas Norman, MD, Oregon Health and Science University
  • Principal Investigator: Richard Carson, MD, Sacred Heart Medical Center (Spokane)

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2013

Primary Completion (Anticipated)

December 1, 2018

Study Registration Dates

First Submitted

June 28, 2013

First Submitted That Met QC Criteria

July 8, 2013

First Posted (Estimate)

July 11, 2013

Study Record Updates

Last Update Posted (Estimate)

September 2, 2016

Last Update Submitted That Met QC Criteria

August 31, 2016

Last Verified

August 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • KPD6172013

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on The Rate of Kidney Transplants in Sensitized Patients.

3
Subscribe